191 related articles for article (PubMed ID: 33799070)
1. New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations.
He X; Nie Y; Zhong M; Li S; Li X; Guo Y; Liu Z; Gao Y; Ding F; Wen D; Zhang Y
Eur J Med Chem; 2021 Jun; 218():113384. PubMed ID: 33799070
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of organoselenium (NSAIDs-SeCN and SeCF
He X; Zhong M; Li S; Li X; Li Y; Li Z; Gao Y; Ding F; Wen D; Lei Y; Zhang Y
Eur J Med Chem; 2020 Dec; 208():112864. PubMed ID: 32987314
[TBL] [Abstract][Full Text] [Related]
3. New Organoselenium (NSAIDs-Selenourea and Isoselenocyanate) Derivatives as Potential Antiproliferative Agents: Synthesis, Biological Evaluation and in Silico Calculations.
Nie Y; Li S; Lu Y; Zhong M; Li X; Zhang Y; He X
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889201
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Potential Anticancer Activity of Some Novel Selenocyanates and Diselenides.
Nie Y; Zhong M; Li S; Li X; Zhang Y; Zhang Y; He X
Chem Biodivers; 2020 May; 17(5):e1900603. PubMed ID: 32198823
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cytotoxicity, antioxidant activity and molecular modeling of new NSAIDs-EBS derivatives.
Zhong M; Lu Y; Li S; Li X; Liu Z; He X; Zhang Y
Eur J Med Chem; 2023 Nov; 259():115662. PubMed ID: 37482018
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiproliferative activity of novel selenoester derivatives.
Domínguez-Álvarez E; Plano D; Font M; Calvo A; Prior C; Jacob C; Palop JA; Sanmartín C
Eur J Med Chem; 2014 Feb; 73():153-66. PubMed ID: 24389510
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma.
Shaaban S; Ashmawy AM; Negm A; Wessjohann LA
Eur J Med Chem; 2019 Oct; 179():515-526. PubMed ID: 31276896
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial synthesis, in silico, molecular and biochemical studies of tetrazole-derived organic selenides with increased selectivity against hepatocellular carcinoma.
Shaaban S; Negm A; Ashmawy AM; Ahmed DM; Wessjohann LA
Eur J Med Chem; 2016 Oct; 122():55-71. PubMed ID: 27343853
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents.
Plano D; Karelia DN; Pandey MK; Spallholz JE; Amin S; Sharma AK
J Med Chem; 2016 Mar; 59(5):1946-59. PubMed ID: 26750401
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
11. Expeditious Entry to Functionalized Pseudo-peptidic Organoselenide Redox Modulators via Sequential Ugi/SN Methodology.
Shaaban S; Negm A; Sobh MA; Wessjohann LA
Anticancer Agents Med Chem; 2016; 16(5):621-32. PubMed ID: 26373394
[TBL] [Abstract][Full Text] [Related]
12. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.
Ruberte AC; Plano D; Encío I; Aydillo C; Sharma AK; Sanmartín C
Eur J Med Chem; 2018 Sep; 157():14-27. PubMed ID: 30071406
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of CF
Han ZZ; Dong T; Ming XX; Kuang F; Zhang CP
ChemMedChem; 2021 Oct; 16(20):3177-3180. PubMed ID: 34268896
[TBL] [Abstract][Full Text] [Related]
14. Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines.
Alcolea V; Plano D; Karelia DN; Palop JA; Amin S; Sanmartín C; Sharma AK
Eur J Med Chem; 2016 May; 113():134-44. PubMed ID: 26922233
[TBL] [Abstract][Full Text] [Related]
15. An investigation of in vitro cytotoxicity and apoptotic potential of aromatic diselenides.
Rizvi MA; Guru S; Naqvi T; Kumar M; Kumbhar N; Akhoon S; Banday S; Singh SK; Bhushan S; Mustafa Peerzada G; Shah BA
Bioorg Med Chem Lett; 2014 Aug; 24(15):3440-6. PubMed ID: 24961641
[TBL] [Abstract][Full Text] [Related]
16. Selenocoumarins as new multitarget antiproliferative agents: Synthesis, biological evaluation and in silico calculations.
Lagunes I; Begines P; Silva A; Galán AR; Puerta A; Fernandes MX; Maya I; Fernández-Bolaños JG; López Ó; Padrón JM
Eur J Med Chem; 2019 Oct; 179():493-501. PubMed ID: 31271961
[TBL] [Abstract][Full Text] [Related]
17. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
[TBL] [Abstract][Full Text] [Related]
19. Organoselenocyanates and symmetrical diselenides redox modulators: Design, synthesis and biological evaluation.
Shaaban S; Negm A; Sobh MA; Wessjohann LA
Eur J Med Chem; 2015 Jun; 97():190-201. PubMed ID: 25969171
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
